Complete Immunophenotypic Reversal of Chronic Lymphocytic Leukaemia With High Dose Parenteral Methylcobalamin: A Case Report and Brief Review of Cobalamin in Cancer.
- 2025-05
- Review
- Cancer reports (Hoboken, N.J.) 8(5)
- Carmen Wheatley
- PubMed: 40347057
- DOI: 10.1002/cnr2.70106
- Low evidence
- Clinical
Complete disappearance of the lymphocytosis also coincided with a severe infection and an even further temporary increase of the parenteral methylcobalamin dose, both catalytic factors.
- Effect
- Beneficial
- Effect size
- Large
- Dose
- 50 mg i.m. a day